SCHEMBL22894110

SCHEMBL22894110

c1ccc(-n2c3ccccc3c3cc4c(cc32)c2ccccc2n4-c2nc(-c3cc4oc5ccccc5c4c4ccccc34)c3ccccc3n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
ATM Q13315 1/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 3/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
ALDH1A1 P00352 6/20 0.32
HPGD P15428 4/20 0.32
MAPT P10636 3/20 0.32
USP2 O75604 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
HSD17B10 Q99714 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22893999 0.93 KDM4E (0.36) KDM4EL3MBTL1ATMNPC1RAB9A
SCHEMBL19239343 0.92 KDM4E (0.38) KDM4EL3MBTL1ATMNPC1RAB9A
SCHEMBL22893941 0.92 NPC1 (0.36) KDM4EL3MBTL1ATMNPC1RAB9A
SCHEMBL22893878 0.92 NPC1 (0.36) KDM4EL3MBTL1ATMNPC1RAB9A
SCHEMBL21213105 0.90 NPC1 (0.37) KDM4EL3MBTL1NPC1RAB9ALMNA
SCHEMBL19239337 0.88 KDM4E (0.38) KDM4EL3MBTL1ATMNPC1RAB9A
SCHEMBL22893997 0.87 SIRT2 (0.33) KDM4EL3MBTL1ATMNPC1RAB9A
SCHEMBL22893940 0.86 NPC1 (0.32) KDM4EL3MBTL1NPC1RAB9ALMNA
SCHEMBL19239412 0.85 KDM4E (0.36) KDM4EL3MBTL1ATMNPC1RAB9A
SCHEMBL22893945 0.84 NPC1 (0.33) L3MBTL1NPC1RAB9ASIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210013411-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KDM4E 2673/4885L3MBTL1 1367/4885ATM 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.